VMD — Viemed Healthcare Income Statement
0.000.00%
Last trade - 00:00HealthcareBalancedSmall Cap
- CA$400.06m
- CA$400.47m
- $138.83m
Annual income statement for Viemed Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 64.5 | 80.3 | 131 | 117 | 139 |
| Cost of Revenue | |||||
| Gross Profit | 47.8 | 56 | 80.1 | 73.4 | 84.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 54.6 | 71.1 | 105 | 105 | 131 |
| Operating Profit | 9.85 | 9.11 | 26.8 | 11.6 | 8.25 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.67 | 8.8 | 26.4 | 12.5 | 8.99 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.51 | 8.53 | 31.5 | 9.13 | 6.22 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.51 | 8.53 | 31.5 | 9.13 | 6.22 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.51 | 8.53 | 31.5 | 9.13 | 6.22 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.241 | 0.223 | 0.741 | 0.232 | 0.162 |